Suchergebnisse - "Xu, Faying"

PubPharm (9)

1

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1

enthalten in: Pharmaceutical biology | 2024

von Li, J. | Ma, X. | Xu, F. | +2

2

Binary classification of non-specific low back pain condition based on the combination of B-mode ultrasound and shear wave elastography at multiple sites

enthalten in: Frontiers in physiology | 2023

von Yu, X. | Xu, X. | Huang, Q. | +12

3

Binary classification of non-specific low back pain condition based on the combination of B-mode ultrasound and shear wave elastography in multiple sites

enthalten in: ResearchSquare.com | 2022

von Yu, X. | Chiang, M. | Zhu, G. | +10

4

Tanshinone IIA improves degranulation of mast cells and allergic rhinitis induced by ovalbumin by inhibiting the PLCγ1/PKC/IP3R pathway

enthalten in: Human & experimental toxicology | 2021

von Li, S. | Li, Z. | Tan, T. | +3

5

Salvinorin A inhibits ovalbumin-stimulated allergic rhinitis and RBL-2H3 cells degranulation

enthalten in: FEBS open bio | 2021

von Shou, Q. | Tan, T. | Xu, F.

6

Salvinorin A inhibits ovalbumin‐stimulated allergic rhinitis and RBL‐2H3 cells degranulation

enthalten in: FEBS Open Bio | 2021

von Shou, Q. | Tan, T. | Xu, F.

7

Wnt signaling in breast cancer : biological mechanisms, challenges and opportunities

enthalten in: Molecular cancer | 2020

von Xu, X. | Zhang, M. | Xu, F. | +1

8

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

enthalten in: Molecular cancer | 2020

von Xu, X. | Zhang, M. | Xu, F. | +1

9

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

enthalten in: Molecular cancer | 2020

von Xu, X. | Zhang, M. | Xu, F. | +1

1
[1]